Skip to main content
. 2020 Sep;73(3):523–532. doi: 10.1016/j.jhep.2020.04.008

Fig. 3.

Fig. 3

Anti-HDV prevalence in HBsAg-positive people.

(A) General populations; (B) Hepatology clinic populations. Each point represents a sample. Point size indicates sample size and colour indicates HDV seroprevalence.